EY new solution Pointellis to support delivery of individualized cancer therapies to patients as per

EY announces the launch of Pointellis, a new solution that supports the provision of individualized therapies that target each cancer patient’s specific treatment needs. The new EY solution is a fully connected data infrastructure that facilitates handoffs of information between unaffiliated entities such as hospitals, laboratories and logistics centers.

Pointellis serves parties involved in individualized cancer therapy, from patients to providers and manufacturers
New solution supports a digital ecosphere and the timely flow of information and materials along the value chain

By maintaining the chain of custody and identity from when a patient’s tissue and blood samples are first obtained, through to treatment administration and long-term monitoring, Pointellis helps cancer patients get their individual treatment in a faster and more secure way. Built on Microsoft Azure, using cross-platform open source frameworks, the solution helps enable a full digital ecosphere that services parties involved in individualized cancer therapy.

With the number of new cancer cases per year expected to exceed 23 million worldwide by 2030, cancer remains one of the world’s most pressing health care challenges due to the costs involved for health care providers and drug manufacturers. This problem will be exacerbated by an aging and growing population worldwide with more patients with cancer seeking treatment in the future.

A digital ecosphere

Bringing together deep analytics knowledge from EY teams with Microsoft technology, Pointellis helps enable the six core function areas of a digital ecosphere. It expedites the timely flow of information and materials along the end-to-end value chain, helping patients to receive the care they need.

The six core functions are:

Biometric chain of identity/custody, to track and trace biopsy tissue and blood samples from point of care when the patient first enters the system, all the way through medicine administration.
Supply chain, to allow for enrolment, scheduling, demand and capacity planning as well as coordination of logistics and delivery.
Patient engagement, to share appropriate information and keep the patient engaged through the waiting process as well as provide disease management information.
Care management, to provide oncologists and health care providers who treat and support critically ill patients with up-to-date information and decision support based on the wealth of data captured through the platform.
Health outcomes, to measure more accurately and allow providers, health systems, payers and manufacturers to adapt treatment and improve clinical benefit.
Funds allotment, to manage the complexities of paying all who are involved with the treatment of a patient.